Finding market leaders in the NEXT economy

Which tech firms and trends are blazing a trail?

clock • 1 min read

For decades, innovative companies with disruptive ideas have achieved stunning stock market success by challenging tradition-bound industries that were unwilling or unable to adapt, writes Mark Baribeau, global head of equity at Jennison Associates.

For decades, innovative companies with disruptive ideas have achieved stunning stock market success by challenging tradition-bound industries that were unwilling or unable to adapt, writes Mark Baribeau, global head of equity at Jennison Associates. In the 1980s, pharmaceutical firms boosted research budgets to battle the planet's most deadly diseases. The digital revolution in the 1990s saw companies like Microsoft and Intel design software and hardware that powered the personal computer revolution. In the 2000s, upstarts such as Google and Amazon.com transformed the way people searc...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Specialist

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

Deep Dive: Thematics offer diversification but investors must consider bond sensitivity

‘Dedicated specialists’

James Baxter-Derrington
clock 06 April 2023 • 4 min read
European private equity yet to spend €270bn worth of capital

European private equity yet to spend €270bn worth of capital

Deployment of capital expected

Kathleen Gallagher
clock 04 January 2023 • 1 min read
Early-stage biopharma: An opportunity for strategic investment

Early-stage biopharma: An opportunity for strategic investment

Disproportionately smaller investment

Ali H. Munawar
clock 10 August 2022 • 4 min read
Trustpilot